Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
Advalight, which offers the ADVATx dermatology laser, announces that Beverly Hills, Calif.-based, board-certified plastic surgeon Daniel Barrett, MD, is now providing its non-ablative laser treatments.